THE RED SECTIONGastric Cancer Consensus Conference Recommends Helicobacter pylori Screening and Treatment in Asymptomatic Persons From High-Risk Populations to Prevent Gastric CancerTalley, Nicholas J. M.D., Ph.D.1; Fock, Kwong Ming M.D.2; Moayyedi, Paul M.D.3 Author Information 1Department of Internal Medicine and Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida; 2Division of Gastroenterology, Department of Medicine, Changi General Hospital, Singapore; and 3Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario, Canada Reprint requests and correspondence: Nicholas J. Talley, M.D., Ph.D., Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224. CONFLICT OF INTEREST Guarantor of the article: Nicholas J. Talley, M.D., Ph.D. Specific author contributions: First draft by NJT; all authors reviewed and edited the drafts and approved the final version. Financial support: None for this review. The consensus conference was supported by the Journal of Gastroenterology and Hepatology, and by the Asian Pacific Association of Gastroenterology. Potential competing interests: Nicholas Talley: Consultant—Astra Zeneca, Cerebrio, Giaconda Ltd., Johnson & Johnson Pharmaceutical R&D, Pfizer, Procter & Gamble, Theravance, Inc., Lexicon Genetics, Inc., Astellas Pharma US, Inc., Pharma Frontiers, Ltd., Callisto Pharmaceuticals. Research support: Takeda, Novartis, GlaxoSmithKline, Dynagen, Tioga. Paul Moayyedi: Advisory Boards/Speaker Bureaus: Nycomed, Astra Zeneca, JanssenOrtho and Esai. American Journal of Gastroenterology: March 2008 - Volume 103 - Issue 3 - p 510-514 Buy Abstract Gastric adenocarcinoma remains a common cause of death worldwide, and there is convincing evidence that this cancer is causally linked to Helicobacter pylori. The first Asian-Pacific Gastric Cancer Consensus brought together leading authorities in the field including the authors, and systematically reviewed all of the available evidence for the role of H. pylori, diet and other risk factors in this malignancy. The consensus conference boldly recommended population-based screening and treatment for H. pylori in particularly high-risk population settings. The evidence for these recommendations is summarized in this report, and the global and U.S. implications are considered. © The American College of Gastroenterology 2008. All Rights Reserved.